Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. [electronic resource]
Producer: 20160919Description: 1277-89 p. digitalISSN:- 2567-689X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anticoagulants -- adverse effects
- Atrial Fibrillation -- blood
- Brain Ischemia -- epidemiology
- Cerebral Hemorrhage -- chemically induced
- Comorbidity
- Dabigatran -- adverse effects
- Databases, Factual
- Drug Evaluation
- Embolism -- epidemiology
- Factor Xa Inhibitors -- adverse effects
- Female
- Follow-Up Studies
- Hemorrhage -- chemically induced
- Hospitalization -- statistics & numerical data
- Humans
- Insurance Coverage
- Male
- Middle Aged
- Myocardial Infarction -- epidemiology
- Polypharmacy
- Propensity Score
- Retrospective Studies
- Stroke -- etiology
- Thrombophilia -- drug therapy
- Treatment Outcome
- Warfarin -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.